Other Areas
Long established as a leader in the U.S. generic pharmaceutical market, Mylan has grown into a worldwide pharmaceutical force and is currently the third largest generics and specialty pharmaceutical company in the world. Mylan holds top-five positions in many established markets worldwide and maintains a commercial footprint that spans more than 150 countries and territories, including areas such as Africa, China, India and South America.
Mylan also owns Somerset Pharmaceuticals Inc., a proprietary research and development company located in Tampa, Fla. Somerset develops EMSAM®*, a transdermal patch for the treatment of major depressive disorder, currently manufactured by Mylan Technologies and marketed in the U.S. by Mylan Specialty (f/k/a Dey).